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Short Communication

PLZF overexpression in T-ALL cell line CEM-C7H2-2C8 downregulates glucocorticoid
receptor (GR) and its target genes
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Abstract: Glucocorticoids (GCs) induce cell cycle arrest and apoptosis in lymphoid cells and constitute a central component in
the treatment of lymphoid malignancies. The molecular basis of this clinically important phenomenon remains, however, poorly
understood. Using whole genome expression profiling we have previously identified glucocorticoid response genes in children with
acute lymphoblastic leukemia (ALL). The promyelocytic leukemia zinc finger (PLZF) appeared as one of the most promising candidate
genes, which has been implicated in the pathogenesis of several leukemia types. We have already established that transgenic PLZF
reduced the sensitivity to GC-induced apoptosis in the CEM-C7H2-2C8 leukemic cell line and knockdown of PLZF resulted in a small
but significant increase in cell death in this cell line. The present study was proposed to find a plausible molecular explanation for this
protective effect of PLZF against GC-induced cell death. It was found that doxycycline-regulated PLZF overexpression in the CCRFCEM T-ALL cell line downregulates the GC-induced GR expression and its target genes, which resulted in reduced apoptosis induced
by GC.
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1. Introduction
Glucocorticoids (GCs) are key elements in the treatment
of childhood acute lymphoblastic leukemia (ALL) and are
components of treatment protocols for other lymphoid
malignancies as well. GCs induce G1 cell cycle arrest and
massive apoptosis in immature lymphoid cells and have a
significant antileukemic effect in the majority of children
with ALL (Schrappe et al., 2000). GC-induced apoptosis
is a phenomenon of considerable biological and clinical
significance. A long list of GC-regulated genes has been
reported in lymphoid lineages and leukemic cell lines
(Schmidt et al., 2004) along with related clinical samples
(Schmidt et al., 2006; Tissing et al., 2007). The most
promising GC-regulated gene identified among them was
the promyelocytic leukemia zinc finger (PLZF) (Schmidt
et al., 2006). Pathogenesis of different types of leukemia
has been reported to be enhanced by impaired PLZF
function, e.g., myeloid leukemia arising from a fusion
protein product of AML-1/ETO. Reports have proven
that in vitro transrepression activity of PLZF is inhibited
by the AML-1/ETO fusion protein product with the ETO
zinc finger domain. This is potentially done by exclusion
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of PLZF from the nucleus to prohibit its binding with
response elements on regulatory areas of target genes
(Melnick et al., 2000).
Most effects of GC are conveyed through the GC
receptor (GR) (Cidlowski et al., 1996). The GR is a
ligand-activated transcription factor of the large nuclear
receptor super family that resides in the cytoplasm and,
upon ligand binding, translocates to the nucleus (Laudet
and Gronemeyer, 2002). In the nucleus, it dimerizes and
binds to so-called GC response elements (GREs), thereby
altering the expression of a plethora of target genes.
Transrepression of gene expression occurs either by direct
binding to negative GREs or, without direct DNA binding,
by protein–protein interactions with other DNA-binding
transcription factors, sequestration of transcription
inducers, or competition for coactivators (Geley et al.,
1997).
In one of our previous studies, we extended our analysis
of GC regulation of PLZF to several leukemic cell lines
and performed functional analyses on the role of PLZF in
the antileukemic effects of GC. We found that transgenic
PLZF alone had no effect on cell proliferation and survival,
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but reduced sensitivity to apoptosis induced by the GC
analogue dexamethasone in the CCRF-CEM model for
T-ALL (Wasim et al., 2010). In this study, we aimed to
propose a molecular explanation for this protective effect
of PLZF on GC-induced apoptosis in the above-mentioned
cell line. Here we found that doxycycline (dox)-induced
overexpression of PLZF downregulates the GR and its
target genes, which might be the likely explanation.
2. Materials and methods
2.1. Cell lines and tissue culture
The T-ALL cell line CEM-C7H2-2C8 (Schmidt et al., 2004),
a CEM-C7H2 derivative with constitutive expression of the
tetracycline-regulated reverse transactivator (rtTA; Schmidt
et al., 2006), and the HEK293T (ATCC) cell line used in
this study were tested for mycoplasma infection and their
authenticity was verified by DNA fingerprinting (Parson
et al., 2005). CEM-C7H2-2C8 was maintained in RPMI
1640 medium, and HEK293T (packaging cell line) cells
were maintained in DMEM. FCS 10%, 2 mM L-glutamine,
100 U/mL penicillin, and 100 µg/mL streptomycin were
added to these culture media as described earlier (Wasim
et al., 2010, 2012). Cells were cultured at 37 °C in 5%
CO2 and saturated humidity and were diluted 1:2 daily or
1:3 every other day to maintain mid log-phase cultures
(2.5–6 × 105 cells/mL). β-Dexamethasone (10−4 M) was
dissolved in 100% ethanol. The final ethanol concentration
in the dexamethasone-treated and control cultures was
maintained at 0.1%. All above reagents were purchased
from Sigma (Vienna, Austria).
2.2. Immunoblotting
Our immunoblotting procedure was published earlier in
detail (Wasim et al., 2010, 2012). In brief, cell pellets (5
× 106 cells) were washed by PBS, lysed in 100 µL of RIPA
buffer, clarified by centrifugation, quantified by Bradford
assay, and mixed with 40 µL of 4X SSB buffer containing
5% β-mercaptoethanol. Total lysate was size-fractioned by
12.5% SDS-PAGE, blotted onto nitrocellulose membranes,
and incubated overnight with primary antibody for PLZF
(Prestige Antibodies, Sigma, HPA00149), GR (E20 from
Santa Cruz Biotechnology, Santa Cruz, CA, USA), and
α-tubulin (DM1A, Calbiochem, Nottingham, UK) as a
protein loading control. The membranes were washed
and then incubated with the antimouse or antirabbit
horseradish-peroxidase conjugated secondary antibody for
45 min at room temperature. After another washing step
immune complexes were visualized using an enhanced
chemiluminescence reagent, ECL Plus (Amersham
Pharmacia Biotech, Amersham, UK) and exposure to
AGFA Curix X-ray films.
2.3. Real-Time RT-PCR
For PLZF, GR, SLA, and PFKFB2 mRNA quantification by
real-time RT-PCR, 20 ng of transcribed cDNA for each gene

was amplified in TaqMan Universal MasterMix (Applied
Biosystems) in 96-well plates using real-time RT-PCR
kits for PLZF ((Hs00232313_m1), GR (Hs00230813_m1),
SLA (Hs00277129_m1), and PFKFB2 (Hs01015408_m1),
as well as TBP (Hs00427620_m1) as the normalization
control. Two-step thermo protocol was followed, which
included 94.5 °C for 5 min in the first step, and then 40
cycles of 94 °C for 15 s alternating with 60 °C for 1 min,
and fluorescence signal intensities were read during the
60 °C temperature step (iQ5 Multicolor Real-Time PCR
Detection System; Bio-Rad Laboratories, Vienna, Austria).
Data from 3 technically replicated measurements were
averaged and normalized to the internal TBP control as
described earlier (Wasim et al., 2010, 2012). Log2-fold
change values (M-values) were calculated for 3 biological
replicates by comparing normalized real-time RT-PCR
data from GC-treated samples against data from the
corresponding control samples. M-values were averaged
for the 3 biological replicates and P-values were calculated
(Student’s t-test) to test against the null hypothesis of no
differential expression (mean M = 0).
3. Results and discussion
We have already reported (Wasim et al., 2010) the
generation, characterization, and functional analysis of 2
stably transduced derivatives of the CCRF-CEM T-ALL
cell line with conditional expression of PLZF, termed
CEM-C7H2-2C8-ZBTB16#19 and #58. Results showed
that transgenic expression of PLZF alone, even at levels that
clearly exceeded those induced by GC, had no detectable
effect on survival or cell cycle progression. However, it
significantly reduced the extent of apoptosis induced
by 10−7 M and, even more so, 10−8 M dexamethasone in
this T-ALL in vitro model. This finding was surprising
and needed a plausible explanation. Hence, this study
was carried out to explore a logical molecular answer.
Therefore, we hypothesized a model (Figure 1) that explains
that GCs transactivate a plethora of genes (proapoptotic),
including PLZF, through GR which ultimately induces
apoptosis. Being a bona fide transcription repressor, PLZF
transrepresses GR and hence its target genes involved
in the induction of the intrinsic pathway of apoptosis,
eventually resulting in reduction of sensitivity to GCinduced apoptosis.
Since GC-induced overexpression of PLZF resulted in
a protective effect (Wasim et al., 2010), we undertook to
investigate whether PLZF overexpression downregulates
GR or not. Real-time RT-PCR confirmed our hypothesis.
We have already established (Wasim et al., 2010) that PLZF
overexpression is regulated by dox. Here we showed that
there is more than 23-fold (ΔΔCT (log2 M value) 5.54)
increase in PLZF level after dox induction (Figure 2A).
This dox-regulated overexpression of PLZF significantly
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Figure 1. Glucocorticoids (GCs) transactivate a plethora of genes
(including proapoptotic genes) through GR, which ultimately
induces apoptosis. PLZF is also regulated by GC through GR.
Being a bona fide transcription repressor, PLZF transrepresses
GR and hence its target genes are involved in the induction of the
intrinsic pathway of apoptosis, eventually resulting in reduction
of sensitivity to GC-induced apoptosis.

downregulated the GC-induced GR expression at
mRNA (Figure 2B) as well as protein (Figure 3) level.
Although apparently inactive as a transcription factor
when tested alone, PLZF significantly interfered with the
transcriptional response to GC in this CCRF-CEM T-ALL
cell line. Since both gene inductions and repressions were
attenuated in the presence of PLZF, and since regulations
of many transcription units were affected, a general
mechanism of action seems likely, such as sequestration of
the activated GR by PLZF (Wasim et al., 2010). A previous
report suggested that PLZF might bind to and inhibit
DNA binding of GR (Martin et al., 2003) to its response
elements, resulting in attenuated expression of its target
genes. Our immunoblot results (Figure 3) tend to suggest
same conclusion. Here the GR band is less prominent due
to PLZF overexpression and slightly translocated towards
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Figure 2. Expression of PLZF (A) and GR (B) mRNA by real-time
RT-PCR, shown as ΔΔCT (log2 M value) in the absence (-dox) or
presence (+dox) of PLZF overexpression. M-value (ΔΔCT) of 1
indicates 2-fold upregulation. Asterisk shows P < 0.01.
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Figure 3. Immunoblot showing the effect of PLZF on GR. Lane
1 shows basal expression of GR, lane 2 shows GR upregulation
by glucocorticoid (dexamethasone), lane 3 shows regulation
of PLZF by dox, and lane 4 shows the decreased GC-induced
expression of GR due to PLZF overexpression.
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Figure 4. Expression of SLA (A) and PFKFB2 (B) mRNA by realtime RT-PCR, shown as ΔΔCT (log2 M value) in the absence
(-dox) or presence (+dox) of PLZF overexpression. M-value
(ΔΔCT) of 1 indicates 2-fold upregulation. Asterisks show P <
0.01.

PLZF, which might be due to protein–protein interaction
between GR and PLZF.
Since GC-regulated expression of GR is under the
inhibitory effect of dox-induced PLZF expression, its
target genes, SLA and PFKFB2, are also downregulated
in same manner (Figures 4A and 4B). It has already been
shown that regulation of GC-response genes is attenuated
under the effect of PLZF expression. One of these
attenuated genes was BCL2L11/Bim (Wasim et al., 2010),
the induction of which was previously shown to play a
crucial role in GC-induced apoptosis in this model system
(Ploner et al., 2008).
In conclusion, we report that dox-regulated PLZF
overexpression in the CCRF-CEM T-ALL cell line
downregulates the GC-induced GR expression and its
target genes, which results in reduced apoptosis induced
by GC. Furthermore, this conclusion suggests the studying
of the possible interaction between PLZF and GR.
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